Kronos Bio Stock (NASDAQ: KRON) stock price, news, charts, stock research, profile.
Open | $0.979 |
Close | $1.000 |
Volume / Avg. | 442.883K / 365.774K |
Day Range | 0.960 - 1.020 |
52 Wk Range | 0.731 - 2.290 |
Market Cap | $60.095M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 1.42% |
Days to Cover | 3.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kronos Bio (NASDAQ: KRON) through any online brokerage.
Other companies in Kronos Bio’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Kronos Bio (NASDAQ: KRON) was reported by Piper Sandler on Tuesday, December 19, 2023. The analyst firm set a price target for 6.00 expecting KRON to rise to within 12 months (a possible 500.00% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Kronos Bio (NASDAQ: KRON) is $1 last updated April 26, 2024 at 5:46 PM EDT.
There are no upcoming dividends for Kronos Bio.
Kronos Bio’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Kronos Bio.
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.